peter attia on semaglutide A new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% 184 - AMA #29: GLP-1

The peptide increases superoxide dismutase (SOD) activity by delivering copper, which serves as a cofactor for this important antioxidant enzyme

* Disclaimer - Based on a comparison of studies measuring weight loss with similar BMI measurements over a 8 week period for active Noom Med patients prescribed a GLP-1 medication and active Noom Healthy Weight customers not taking medication

Tirzepatide (Mounjaro, Zepbound, compounded) Tirzepatide is a dual GIP/GLP-1 receptor agonist, which means its mechanism differs slightly from pure GLP-1 medications

Side Effects and Important Precautions Glutathione is generally well tolerated when prescribed and supervised by a qualified doctor but it is not risk-free, and the IV route in particular needs caution

RegenCen provides physician-guided testosterone therapy designed to restore levels to a healthy physiologic range while monitoring long-term health and treatment response

Semaglutide is FDA-approved and prescribed under medical supervision to ensure safety and effectiveness